Raise needed yes.That size discount to such a world class asset - definite no.
Could have done the MRE then raised the same money for many less shares.
Dilution always happens - the unnecessary degree of which is the issue.
Having said that we don't know what pressures were brought to bear within the 'chairman's list'.
- Forums
- ASX - By Stock
- LIN
- Third Tranche
Third Tranche, page-42
Featured News
Add LIN (ASX) to my watchlist
|
|||||
Last
14.5¢ |
Change
-0.010(6.45%) |
Mkt cap ! $167.1M |
Open | High | Low | Value | Volume |
15.5¢ | 16.8¢ | 14.5¢ | $1.101M | 7.092M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 225182 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 83396 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 50016 | 0.150 |
8 | 237082 | 0.145 |
8 | 370286 | 0.140 |
3 | 69698 | 0.135 |
4 | 134000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 55500 | 1 |
0.145 | 403893 | 2 |
0.150 | 78128 | 3 |
0.155 | 92922 | 4 |
0.160 | 116360 | 1 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
LIN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online